Video Shorts

0:43
FDA's Shift: Why Predictability Now Matters More Than Speed
4 hours ago
by
Mike Hollan(+1 more)

0:45
Using Data to Come to the Right Conclusions
a day ago
by
Mike Hollan(+1 more)

1:12
Market Watch Rx: Humana Leads Top Gainers
6 days ago
by
Nicholas Jacobus

0:53
FDA Leadership Turnover Explained
8 days ago
by
Mike Hollan(+1 more)

1:19
Market Watch Rx: Eli Lilly Joins Top Gainers
13 days ago
by
Nicholas Jacobus

0:49
Why the US Healthcare System is Fragmented
17 days ago
by
Mike Hollan(+1 more)

0:32
Why Patient Care is the Heart of Pharma Business
17 days ago
by
Mike Hollan(+1 more)

1:15
Market Watch Rx: West Pharmaceutical Services Leads Gainers
20 days ago
by
Nicholas Jacobus

0:32
Why 'Just-In-Time' Delivery is a Trap
21 days ago
by
Nicholas Jacobus(+1 more)

0:29
The United State's Regulatory Impact on Global Drug Launches
24 days ago
by
Mike Hollan(+1 more)

1:08
Market Watch Rx: Johnson & Johnson Shares Slide
a month ago
by
Nicholas Jacobus

0:40
Real Hope: The Best Part of Being an Oncologist
a month ago
by
Nicholas Jacobus(+1 more)

0:46
How Platform Technologies and Partnerships are Shaping CGT Development
a month ago
by
Mike Hollan(+1 more)

0:43
Branding's Hidden Power
a month ago
by
Michael Christel(+1 more)

1:09
Market Watch Rx: Roche Joins Top Gainers
a month ago
by
Nicholas Jacobus

0:42
Addressing the Biosimilar Void in the U.S. Market
a month ago
by
Mike Hollan(+1 more)

1:13
Market Watch Rx: Humana Leads Gainers
a month ago
by
Nicholas Jacobus

0:40
The Relationship Between Muscle Building and GLP-1s
a month ago
by
Mike Hollan(+1 more)

0:56
Drug Policy Shift: MFN's Impact on Providers
2 months ago
by
Mike Hollan(+1 more)

0:50
The Weird Connection Between Cancer and Heart Attacks
2 months ago

1:01
Market Watch Rx: Merck Joins Top Gainers
2 months ago
by
Nicholas Jacobus

0:50
Why China’s R&D Model is Thriving
2 months ago
by
Michael Christel(+2 more)

0:34
Takeaways from Day One at Access USA 2026
2 months ago
by
Nicholas Jacobus(+1 more)

1:01
Market Watch Rx: Intellia Therapeutics Leads Gainers
2 months ago
by
Nicholas Jacobus

1:08
What You Need to Know: MFN, Healthcare Spending, and Compounded Medications
2 months ago
by
Mike Hollan

0:42
What Can Help Patient Support Operations?
2 months ago
by
Nicholas Jacobus(+1 more)

1:41
2026 Drug Pipeline Report
2 months ago
by
Michael Christel

0:51
Measuring Good Patient Access from Bad Patient Access
2 months ago
by
Nicholas Jacobus(+1 more)

0:30
Can't Afford Your Meds? Watch This
2 months ago
by
Nicholas Jacobus(+1 more)
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5

